在免疫炎症疾病中应用PROTACs
Chao Zhang1, Xiuyun Sun1, Peilu Song2
1Changping Laboratory, Beijing 102206, China.
Bioorganic & medicinal chemistry
|October 31, 2024
概括
针对蛋白质分解的仿真体 (PROTACs) 通过选择性降解引起疾病的蛋白质,为免疫炎症疾病提供了一种新的治疗方法. 这种创新的小分子技术克服了当前治疗方法的局限性,显示出改善患者结果的重大前景.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 免疫-炎症性疾病是普遍和衰弱的,当前的治疗方法,如免疫抑制剂和单克隆抗体面临的局限性,如不良的交付和免疫性.
- 小分子药物也有缺点,包括选择性差和无法准非酶蛋白功能.
- 现有的治疗策略受到这些局限性的限制,影响了免疫炎症疾病的治疗有效性.
研究的目的:
- 在免疫炎症领域全面审查向蛋白质分解的仿真体 (PROTACs) 的应用.
- 突出PROTAC技术的潜力,作为一种针对免疫炎症疾病的新型治疗策略.
主要方法:
- 本综述综合了关于PROTAC技术的现有研究及其在免疫炎症疾病模型中的应用.
- 专注于PROTACs的作用机制,通过E3无素连接酶诱导向蛋白质降解.
- 检查了在临床前和临床研究中与PROTACs相关的治疗疗效和挑战.
主要成果:
- PROTAC技术通过劫持细胞的无素-蛋白酶体系统,实现了针对性的蛋白质降解.
- 在各种免疫炎症疾病模型中,PROTACs已经证明了有前途的治疗效果,克服了传统疗法的局限性.
- 该技术显示了在治疗复杂的免疫炎症疾病时,提高选择性和疗效的潜力.
结论:
- 在用于免疫炎症疾病的小分子药物开发中,PROTACs代表了突破性的进步.
- 这项技术为克服当前治疗方法的局限性和改善患者生活质量提供了一个有希望的新途径.
- 需要对PROTAC进行进一步的研究和临床开发,以充分实现其在免疫炎症中的治疗潜力.
更多相关视频
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
3.3K
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
相关概念视频
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
T Cell Activation and Clonal Selection
672
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
672
